NEW YORK (AP) — Stocks were mixed in early Tuesday trading as investors return from a long holiday weekend. Coca-Cola slumped after turning in disappointing quarterly results and health care stocks rose following news a big merger in the pharmaceutical sector.
KEEPING SCORE: The Dow Jones industrial average lost 11 points, or 0.1 percent, to 16,142 as of 10 a.m. Eastern. The Standard & Poor's 500 index lost less than a point to 1,839 and the Nasdaq composite was up seven points, or 0.2 percent, to 4,251.
PHARMA DEAL: Forest Laboratories jumped $21.28, or 30 percent, to $92.70 after another drugmaker, Actavis, agreed to buy the company for $25 billion. Actavis makes the generic versions of hyperactivity disorder medication Concerta and the cholesterol drug Lipitor, while Forest makes the Alzheimer's treatment Namenda. Actavis rose $15.06, or 8 percent, to $206.10.
Other health-care stocks also rose. Gilead Sciences rose 2 percent and UnitedHealth Care and Amgen increased 1 percent in early trading.
LOSING ITS FIZZ: Coca-Cola dropped $1.50, or 4 percent, to $37.43 after reporting a decline in fourth-quarter profit and sales from a year ago. The company, which also makes Sprite, Dasani and Vitaminwater, says sales volume declined 1 percent in North America.
BACK FROM HOLIDAY WEEKEND: U.S. financial markets were closed Monday in observance of President's Day.
Original headline: Stocks open flat after holiday weekend; Coke falls
Most Popular Stories
- Chobani Counters Competition With Expanded Lineup
- Twitter Offers App Install Ads
- What to Expect From an Amazon Smartphone
- Asia Seeks Obama's Assurance Over Spats
- Nevada Range Showdown Draws Armed Supporters
- Coachella's Young Audience a Marketers Paradise
- Putin: No Blocks to Boosting Relations With West
- NASA's Space Station Robonaut Finally Getting Legs
- National Energy Boom Blurs Political Battle Lines
- Auto Parts Plant Opening in Pa., Jobs on Tap